Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
Home News
  • Choose Chemspace!

    Looking for a source to start a Virtual Screening campaign?

    Need access to a diverse Chemical Space provided by reliable suppliers?

    Choose Chemspace!

  • N-Trifluoromethyl Azoles

    Last October, a group of researchers published a study that describes usage of strategy to improve activity of amines and azoles through installation of N-trifluoromethyl group and investigation of their properties. Comparing the stability of N-trifluoromethyl amines and N-trifluoromethyl azoles in aqueous media showed that the latter compounds are stable, and the former ones are prone to hydrolysis. The authors also showed that the N-trifluoromethyl azoles have higher lipophilicity than N-methyl analogs and can show increased metabolic stability and Caco-2 permeability.
    We at Chemspace have selected two sets with derivatives of N-trifluoromethyl-imidazole and N-trifluoromethyl-pyrazole.

  • Chemspace & Molecular Forecaster Webinar. Recording

    Thanks everyone for joining the webinar yesterday! For those who didn’t have a chance to connect, the recording is already available.

  • Molecules of This Week are Phenols

    Phenols are the Molecules of This Week. We at Chemspace always have new small molecules to power up your research. To browse the set please use the link.

  • Announcement of Chemspace & Molecular Forecaster Webinar Tomorrow

    Dear friends and colleagues! Join the Chemspace & Molecular Forecaster Webinar 'Democratizing computer-aided drug design with accessible services, software, and molecules', which will take place at 5:00 PM (CET)/11:00 AM (EST) TOMORROW.

  • Analogs to New Biological Tool Compounds

    We are happy to announce a new content series inspired by Drug Hunter’s “Small Molecules of the Month” series (drug-hunter.com)!

    Drug Hunter’s “Small Molecules of the Month” articles provide insights on recent developments in drug discovery including recently published biological tool compounds, lead molecules, and drug candidates. Chemspace can support additional research in these areas with commercial samples of these new molecules as well as their analogs selected from the largest catalog of over 6.5M off-the-shelf and 1.6B made-on-demand small molecules from world-renown vendors.

  • Building Blocks for Analogs of Vericiguat

    This January, Vericiguat (VERQUVO) received approval by FDA as a drug for patients who have symptomatic, chronic heart failure with reduced ejection fraction (HFrEF).

    It targets cyclic guanosine monophosphate (cGMP), as a means to lower the risk of cardiovascular events in high-risk patients. Vericiguat stimulates soluble guanylate cyclase (sGC) to produce cGMP and restore nitric oxide sensitivity. By increasing cGMP production, Vericiguat decreases arterial constriction and arterial stiffness.

  • News Digest. January 2021.

    Meet Chemspace Monthly Digest! 

     

    Here is a summary of all Chemspace news and highlights for January in case you have missed them!

  • Announcement of Chemspace & Molecular Forecaster Webinar

    Dear friends and colleagues!
    Join the Chemspace & Molecular Forecaster Webinar 'Democratizing computer-aided drug design with accessible services, software, and molecules', which will take place at 5:00 PM (CET)/11:00 AM (EST) on February, 11.

  • Molecules of This Week are Aliphatic Sulfonylhalides

    Aliphatic Sulfonylhalides are the Molecules of This Week. We at Chemspace always have new small molecules to power up your research. To browse the set please use the link.

  • Chemspace & Enamine Webinar. Recording

    Thanks everyone for joining the webinar yesterday! For those who didn’t have a chance to connect, the recording is already available!

  • Selleck Chemicals - OUR NEW SUPPLIER!

    Dear friends and colleagues!
    We are happy to announce that Selleck Chemicals has joined Chemspace platform!
    Selleck Chemicals actively tracks the latest science publications so customers can rely on them as the leading supplier of the newest bioactive compounds and probes.
    Now more than 6 000 compounds supplied by Selleck Chemicals are available via Chemspace!

  • Announcement of Chemspace & Enamine Webinar Tomorrow

    Dear friends and colleagues!
    Join the Chemspace & Enamine Webinar 'Research at Enamine: a review of recent scientific publications', which will take place Tomorrow at 5:00 PM (CET).
    In this webinar, Dr. Oleksandr Grygorenko will give a talk on recent papers from the Scientific Support Department and its collaborators, providing a brief view on a huge diversity of chemistries done at Enamine Ltd.

  • Drug Candidate Analogs. “Compound 25”

    Last October, the article 'Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory Activity' describing identification of a potent inhibitor of the unfolded protein response (UPR) regulating potential anticancer target IRE1α was published.

    Substitution of the amino-quinazoline moiety in initial clinical candidate to amino-thienopyrimidine (“Compound 25”) shows more than the 1000-fold decrease in BRaf activity with the same good IRE1α cellular potency.

  • Announcement of Chemspace & Enamine Webinar

    Dear friends and colleagues!
    Join the Chemspace & Enamine Webinar 'Research at Enamine: a review of recent scientific publications', which will take place at 5:00 PM (CET) on January, 28.
    In this webinar, Dr. Oleksandr Grygorenko will give a talk on recent papers from the Scientific Support Department and its collaborators, providing a brief view on a huge diversity of chemistries done at Enamine Ltd.

  • Molecules of This Week are Fluoro-Thiols

    Fluoro-Thiols are the Molecules of This Week. We at Chemspace always have new small molecules to power up your research. To browse the set please use the link.

  • Building Blocks for Analogs of Relugolix

    In December 2020, Relugolix (ORGOVYX) received approval by the FDA for the treatment of adult patients with advanced prostate cancer.

    It is a selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR). Unlike most other GnRH modulators, Relugolix is a non-peptide and small-molecule compound and is orally active.

    This drug contains 2-aminothiophene-3-carboxylic acid moiety in its backbone.

    We have made a set of Building Blocks, which contain Thiophene, 1H-Pyrrole and Furan carboxylic acid parts – the perfect start for your research!

  • News Digest. December 2020

    Meet Chemspace Monthly Digest! 


    Here is a summary of all Chemspace news and highlights for December in case you have missed them.

  • Molecules of This Week are Aliphatic Alcohols

    Aliphatic Alcohols are the Molecules of This Week. We at Chemspace always have new small molecules to power up your research. To browse the set please use the link.

  • Drug Candidate Analogs. "BAY 1217224"

    This October, the article 'Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics' describing research of small molecule thrombin inhibitors for the oral application was published.

    Knowledge of the protein structure and the pregnane X receptor (PXR) helped to overcome a persistent cytochrome P450 3A4 induction problem. After successful design, synthesis, and testing, researches selected series "BAY 1217224" for further development.

  • Non-Classical Phenyl Bioisosteres

    This July, a group of researchers published an article 'Non-Classical Phenyl Bioisosteres as Effective Replacements in a Series of Novel Open Source Antimalarials'. The paper describes the study of some analogs of phenyl group in a series of drug candidates against malaria. The results show that cubane and closo-carborane analogues exhibit improved in vitro potency while bicyclo[1.1.1]pentane (BCP) analogue is equipotent against Plasmodium falciparum (compared to the parent phenyl-containing compound). The former analogs show some changes in metabolic stability.

  • Shape‐Diverse 3D Fragments

    In April 2020, a group of researchers published an article 'Design and Synthesis of 56 Shape‐Diverse 3D Fragments'.
    The paper describes a workflow for the design and synthesis of 56 3D disubstituted pyrrolidine and piperidine fragments which occupy under-represented areas of fragment space. These 3D fragments were designed to contain suitable synthetic handles for future fragment elaboration. Comparing these 3D fragments with six commercial libraries, the authors showed that the new collection has high three‐dimensionality and shape diversity.

  • Building Blocks for Analogs of Lonafarnib

    This November, Lonafarnib (ZOKINVY) received approval by the FDA as a drug to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients one year of age and older.
    Lonafarnib, a farnesyltransferase inhibitor, is an oral medication that helps prevent the buildup of defective progerin or progerin-like protein.

    This drug contains 4-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene moiety in its backbone.

    We have made a set of Building Blocks, which contain such part – the perfect start for your research!

  • Molecules of This Week are 1,3-Dioxane-5-Amines

    1,3-Dioxane-5-Amines are the Molecules of This Week. We at Chemspace always have new small molecules to power up your research. To browse the set please use the link.

  • Now you can specify type of products while submitting your query!

    Now you can specify the type of products while submitting your query on Chemspace, the largest online catalog of small molecules! Please, try this link!

Showing 651-675 of 898 items.